CytoDyn CYDY
OTC CYDY
$0.24 -0.01 (-4.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

CytoDyn (CYDY) Gross Margin (2021)

Updated

CytoDyn's Gross Margin came in at 71.00% for FY2022 (year ended May 31, 2022).

Analysis

CytoDyn (CYDY) Gross Margin (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 85.78%
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 68.12%
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 74.74%
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 73.54%
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 78.02%
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 83.60%
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 72.04%
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 79.76%
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 72.78%
10 CytoDyn 352.68 Mn 303.84 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2021 76.89%
Aug 31, 2021 97.56%
API Access

CytoDyn Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=CYDY&period=max&api_key=YOUR_API_KEY